Most convincingly, dichloroacetate inhibits PDK1, activates pyruvate dehydrogenase, and reverses the glycolytic shift and the resistance to apoptosis, leading to the inhibition of PH in experimental models50,51 and in genetically susceptible PAH patients52. Here, PDK1 is linked to pulmonary arterial hypertension.